A new daily pill being developed by US-based biotech firm Loyal could extend the lifespan of senior dogs while maintaining their quality of life.
The experimental drug, called LOY-002, is designed for dogs aged 10 and older, particularly those weighing over 14 pounds.
LOY-002 targets a hormone known as Insulin-Like Growth Factor 1 (IGF-1), which plays a key role in growth and metabolism.
By reducing IGF-1 levels, LOY-002 aims to slow down the biological aging process, potentially adding years to a dog’s life.
The drug has already cleared two out of three required stages for approval by the US Food and Drug Administration and could be available before the end of 2026 if it receives final regulatory approval.
